期刊文献+

抗肺结核药物研究进展 被引量:3

Progress of Research on Antimycobacterial Drugs
下载PDF
导出
摘要 由于艾滋病和细菌耐药性的出现 ,结核病日益成为全球健康关注问题。目前迫切需要新的化学治疗药物。本文介绍一些具有抗结核分支杆菌活性的新化合物 ,如氟喹诺酮、唑烷酮。 Mycobacterium tuberculosis (TB) becomes a growing international health concern because of the emergence of multi-drug-resistance of mycobacteria and AIDS. So, there is a pressing need for new effective anti-TB agents. This review summerizes the progress of some novel anti-TB compounds such as fluoroquinolones, oxazolidinones, alkylsulfonyl derivatives and nitroimidazopyrans.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2002年第3期147-151,共5页 Chinese Journal of Pharmaceuticals
关键词 结核分支杆菌 抗结核药物 药物研究 进展 mycobacterium tuberculosis anti-TB agents review
  • 相关文献

参考文献26

  • 1[1]Parrish NM, Dick JD,Bishai WR. Mechanisms of latency in mycobacterium tuberculosis [J].Trends Microbiol, 1998,6:107-112.
  • 2[2]何广学.世界防治结核病的意义[N].中国医药报,2001-03-24(2).
  • 3[3]周欣.中国结核病的流行趋势[N].中国医药报,2001-03-25(1).
  • 4[4]Anon. TB still increasing despite DOTS [J]. Scrip, 2001,(2630):16.
  • 5[5]Jacobs MR. Activity of quinolones against mycobacteria [J]. Drugs, 1999,58(Suppl 2):19-22.
  • 6[6]Ruiz-Serrano MJ, Alcala L, Martinez L, et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs [J]. Antimicrob Agents Chemother, 2000,44(9):2567-2568.
  • 7[7]Tomioka H, Sato K, Kajitani H, et al. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155),and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex [J]. Antimicrob Agents Chemother, 1999,43:3001-3004.
  • 8[8]Tomioka H, Sato K, Kajitani H,et al. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034,levofloxacin, sparfloxacin and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex[J]. Antimicrob Agents Chemther, 2000,44:283-286.
  • 9[9]Satio H. Comparative antimycobacterial activity of BAY-12-8039 and gatifloxacin [J]. Drugs, 1999,58(Suppl 2): 401.
  • 10[10]Ji BH, Lounis N, Maslo c, et al. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis [J].Antimicrob Agents Chemother, 1998,42:2066-2069.

同被引文献90

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部